Health Law and Regulation

The U.S. Department of Health and Human Services (HHS) and Cleveland Clinic are teaming up to raise awareness about deep brain stimulation (DBS) and its impact on Americans with neurological disorders and disabilities.

HHS’ Office on Disability and Cleveland Clinic’s Center for Neurological Restoration will hold a conference to focus on the impact DBS, or brain pacemakers, has on patients’ quality of life, level of functioning and return to work. Topics will also include improving access to care, encouraging medical innovation and research and examining ethical considerations.

Currently, DBS is approved by HHS’ Food and Drug Administration (FDA) for Parkinson’s disease, essential tremor and dystonia. Data is emerging regarding its benefit in treating patients with obsessive compulsive disorder (OCD), depression and most recently, traumatic brain injury (TBI).

“We are approaching a defining moment in the neurological field,” said Ali Rezai, M.D., director of the Center for Neurological Restoration at Cleveland Clinic, and meeting co-chair. “This is the beginning of a new era for treating neurological and psychiatric disorders. DBS technology continues to improve, and we are encouraged by the results in patients.”

Source: The U.S. Department of Health and Human Services, April 25, 2008

Neurology and Neurosurgery: Clinical Guidelines for Managing Care, 2nd Edition

This 200-page report includes 84 clinical evidence-based review criteria for outpatient and inpatient tests and procedures with indications, medical necessity coverage criteria, references and resources, plus Alzheimer disease.

Neurology and Neurosurgery: Clinical Guidelines for Managing Care, 2nd Edition is available from the Healthcare Intelligence Network for $72.50 by visiting our Online Bookstore or by calling toll-free (888) 446-3530.